Gamma-interferon reduces expression of the protooncogene c-erbB-2 in human ovarian carcinoma cells.
Cancer Res
; 50(21): 7037-41, 1990 Nov 01.
Article
en En
| MEDLINE
| ID: mdl-2119884
ABSTRACT
The overexpression of the protooncogene c-erbB-2 (HER-2/neu) in ovarian and mammary carcinoma is an important indicator for a bad prognosis. In this study we demonstrate that, in three of four ovarian carcinoma cell lines, there is a gamma-interferon-mediated reduction in c-erbB-2 specific protein, and this effect was found to correlate with the antiproliferative action. It is interesting to note that there is no relation between the absolute amount of c-erbB-2 protein expressed and the sensitivity of the ovarian carcinoma cells for an antiproliferative activity of gamma-interferon. Other chemotherapeutic agents did not affect c-erbB-2 expression, although they inhibited the proliferation. The oncogene expression was lowered only in the ovarian carcinoma cell lines and not in three gamma-interferon-sensitive human breast cancer cell lines. Expression of the oncogene c-erbB-2 is the leading prognostic factor in ovarian cancer. Its modulation might represent a mechanism by which gamma-interferon inhibits cell proliferation.
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Neoplasias Ováricas
/
Proto-Oncogenes
/
Carcinoma
/
Regulación Neoplásica de la Expresión Génica
/
Interferón gamma
Tipo de estudio:
Prognostic_studies
Límite:
Female
/
Humans
/
Male
Idioma:
En
Año:
1990
Tipo del documento:
Article